Canopy Growth Corp Derivative Liability, Noncurrent
Canopy Growth Corp (CGC) had Derivative Liability, Noncurrent of CAD 11.04 million as of 2025-12-31, per its 10-K filed 2026-06-15.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:DerivativeLiabilitiesNoncurrent · last filed 2026-06-15
- 2025-12-31: Derivative Liability, Noncurrent 11.04M CAD.
- 2025-09-30: Derivative Liability, Noncurrent 15.32M CAD.
- 2025-06-30: Derivative Liability, Noncurrent 11.98M CAD.
- 2025-03-31: Derivative Liability, Noncurrent 8.65M CAD.
| Period end | Derivative Liability, Noncurrent |
|---|---|
| 2025-12-31 | 11.04M CAD 10-K · filed 2026-06-15 |
| 2025-09-30 | 15.32M CAD 10-K · filed 2026-06-15 |
| 2025-06-30 | 11.98M CAD 10-K · filed 2026-06-15 |
| 2025-03-31 | 8.65M CAD 10-K · filed 2026-06-15 |
| 2024-12-31 | 33.48M CAD 10-K · filed 2026-06-15 |
| 2024-09-30 | 45.35M CAD 10-K · filed 2026-06-15 |
| 2024-06-30 | 65.80M CAD 10-K · filed 2026-06-15 |
| 2024-03-31 | 99.94M CAD 10-K · filed 2026-06-15 |
| 2023-12-31 | 9.53M CAD 10-K · filed 2026-06-15 |
| 2023-09-30 | 20.66M CAD 10-K · filed 2026-06-15 |
| 2022-12-31 | 668.00K CAD 10-Q · filed 2023-02-09 |
| 2022-09-30 | 691.00K CAD 10-Q · filed 2022-11-09 |
| 2022-06-30 | 1.55M CAD 10-Q · filed 2022-08-09 |
| 2022-03-31 | 26.92M CAD 10-K · filed 2023-06-22 |
| 2021-03-31 | 615.58M CAD 10-K · filed 2022-05-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |